2012-29300. National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering.

    The meeting will be open to the public as indicated below. This will be a virtual meeting. Please log on to the following URL: https://webmeeting.nih.gov/​nacbibopen/​ to join the open session. If you have questions please notify the Contact Person listed below in advance of the meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering NACBIB, January 25, 2013, Virtual Meeting.

    Date: January 25, 2013.

    Open: 11:00 a.m. to 11:30 a.m.

    Agenda: Report from the Institute Director and other Institute Staff.

    Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Suite 200, Room 241, Bethesda, MD 20892.

    Closed: 11:45 a.m. to 1:00 p.m.

    Agenda: To review and evaluate grant applications and/or proposals.

    Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Suite 200, Room 241, Bethesda, MD 20892.

    Contact Person: Anthony Demsey, Ph.D., Director, National Institute of Biomedical Start Printed Page 72366Imaging and Bioengineering, 6707 Democracy Boulevard, Room 241, Bethesda, MD 20892.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Information is also available on the Institute's/Center's home page: http://www.nibib1.nih.gov/​about/​NACBIB/​NACBIB.htm,, where an agenda and any additional information for the meeting will be posted when available.

    Start Signature

    Dated: November 29, 2012.

    David Clary,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2012-29300 Filed 12-4-12; 8:45 am]

    BILLING CODE 4140-01-P